Nicergoline Cas number is 27848-84-6, it is used for acute or chronic cerebrovascular disorders or cerebral metabolic dysfunction. It also can treat chronic cerebral insufficiency caused by mobility problems, language disorders, tinnitus, dizziness, vision disorders, dizziness, headache, insomnia, memory loss, inability to concentrate, mental depression, anxiety, agitation and senile dementia. Nicergoline can enhance the role of antihypertensive drugs. The main adverse reactions are mild gastrointestinal discomfort, flushing, drowsiness, insomnia. A high dose of nicergoline may cause a temporary decrease in blood pressure. Generally do not need treatment, supine rest for a few minutes. Rare cases of cerebral and cardiac insufficiency, it is recommended in continuous blood pressure monitoring, given sympathomimetic drugs.

Thera. Category:  Treat senile dementia and other disorders with vascular origins 

Cas No.:27848-84-6

Synonyms:  +)-10-methoxy-1,6-dimethylergoline-8-beta-methanol5-bromonicotinate;10-methoxy-1,6-dimethyl-ergolin-8-beta-methanol-(5-bromnicotinat);10-methoxy-1,6-dimethyl-ergoline-8-beta-methano5-bromo-3-pyridinecarboxy;10-methoxy-1,6-dimethyl-ergoline-8-beta-methano5-bromonicotinate(ester);10-methoxy-1,6-dimethylergoline-8-methanol5-bromo-3-pyrindinecarboxylate(es;1-methyl-lumilysergol8-(5-bromonicotinate)10-methylether;8-beta-((5-bromonicotinoyloxy)methyl)-1,6-dimethyl-10-alpha-methoxyergoline;fi6714

Molecular Formula:C24H26BrN3O3

Molecular Weight: 484.39

Purity: ≥99%

Packing: Export worthy packing

Material Safety Data Sheet: Available on request

Usage: Pharmaceutical Intermediate